Hekmat Medicinal Chemistry Development Co. is a knowledge-based company located in Alborz province, dedicated to the production of advanced pharmaceutical intermediates. Our primary objective is to create LVHV (Low Volume, High Value) intermediates using easily accessible chemicals, preferably sourced from the Iranian petrochemical industry.

At Hekmat Medicinal Chemistry, we strive to integrate the latest achievements in organic synthesis into our projects, thereby contributing to the advancement of the field. By harnessing recent organic synthesis breakthroughs, we aim to enhance the development of our pharmaceutical intermediates and optimize their production processes.

We recognize the value of utilizing fine chemicals derived from the Iranian petrochemical industry, as it not only provides a cost-effective solution but also promotes sustainability. This approach allows us to access high-quality starting materials for pharmaceutical synthesis while supporting the local industry.

By staying at the forefront of organic synthesis advancements, we ensure that our projects benefit from the most up-to-date strategies, methodologies, and techniques. This commitment enables us to streamline synthesis routes, improve yields, and meet the highest standards of quality and safety in our intermediates.

We actively seek collaboration with academic institutions, research organizations, and industry experts. Through these partnerships, we foster a culture of innovation, knowledge exchange, and continuous improvement within our company. By engaging with the broader scientific community, we remain informed about emerging trends, novel synthetic methodologies, and environmentally friendly approaches.

Hekmat Medicinal Chemistry Development Co. is dedicated to producing LVHV intermediates by utilizing readily available chemicals from the Iranian petrochemical industry. We strive to incorporate the latest organic synthesis achievements to optimize our processes, enhance product quality, and contribute to the development of the pharmaceutical industry.